Wed Mar 20, 2013 9:03am EDT

* Reuters is not responsible for the content in this press release.

  SANTA BARBARA, CA, Mar 20 (Marketwire) -- 
USDM, a leading global regulatory consulting firm in the life sciences
space, is proud to announce their strategic partnership with Accelrys,
Inc. (NASDAQ: ACCL), a leading provider of scientific innovation
lifecycle management software. 

    "USDM is excited to partner with Accelrys to bring innovation to the
lab," said Diane Gleinser, vice president of USDM's Laboratory Practice.
"Accelrys' products, combined with USDM's regulatory knowledge and life
science experience, are changing the way labs operate. Efficiency and
compliance now go hand in hand to reduce costs and increase
productivity." 

    "Accelrys partnering with USDM is a win-win for life sciences
organizations in regulated environments," said Ken Rapp, managing
director of Accelrys ADQM Solutions. "The combination of Accelrys'
market-leading process management and compliance products and services
with USDM's best-practice regulatory compliance and risk management
solutions returns data control and process monitoring to the scientists
who are in need of harmonized capabilities in these critical areas."

    Supporting these technology offerings, USDM brings a strong, proven
professional services organization to assist customers in qualification,
validation, auditing, risk management and other compliance-related
projects, including implementation and IT architecture services for
Accelrys LIMS. Together, the Accelrys and USDM team will perform all
needed preliminary project/business needs assessments, piloting of the
solution, initial deployments with qualification/validation and roll-out
to the customer site, multiple sites or global operations.

    About USDM:
 USDM is a leading global regulatory consulting firm
providing compliance, business intelligence, validation, qualification,
quality, auditing, and IT services to our clients in the life sciences
industries. USDM has partnerships, expertise and solutions for critical
Life Science technologies -- Oracle, SAP, ServiceMax, Salesforce,
Microsoft, Qumas, and others. USDM has more than 12 years of experience
supplying our clients with compliant solutions in each phase of their
drug and product development cycle, partnering with best of breed ISVs to
help companies unify and optimize their business and compliance
processes. USDM provides a comprehensive enterprise solution to support
US, EMEA, and Asian regulatory requirements for regulated applications. 

    About Accelrys, Inc.
  Accelrys, Inc. (NASDAQ: ACCL), a leading provider
of scientific innovation lifecycle management software, supports
industries and organizations that rely on scientific innovation to
differentiate themselves. The industry-leading Accelrys Enterprise
Platform provides a broad and flexible scientific solution optimized to
integrate the diversity of science, experimental processes and
information requirements across the research, development, process
scale-up and early manufacturing phases of product development. By
incorporating capabilities in applications for modeling and simulation,
enterprise lab management, workflow and automation, and data management
and informatics, Accelrys enables scientific innovators to access,
organize, analyze and share data in unprecedented ways, ultimately
enhancing innovation, improving productivity and compliance, reducing
costs and speeding time from lab to market. For more information about
Accelrys, visit www.accelrys.com. 

    

USDM
535 Chapala St. 
Santa Barbara, CA 93101
usdm.com
Phone: 888.231.0816 

Copyright 2013, Marketwire, All rights reserved.

-0-